Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
BioLife Solutions ( (BLFS) ) just unveiled an update.
BioLife Solutions has appointed Tony J. Hunt, Executive Chairman of Repligen Corporation, to its board of directors effective January 2, 2025. Mr. Hunt, recognized for his leadership in bioprocessing innovation, is expected to enhance BioLife’s strategic focus on the CGT market with his extensive industry experience, contributing to the company’s growth and innovation efforts. This appointment reflects BioLife’s commitment to strengthening its position in the bioprocessing sector and supporting its mission of delivering top-tier bioproduction workflows.
More about BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction tools and services aimed at the cell and gene therapy (CGT) market. The company specializes in providing solutions that ensure the health and functionality of biological materials during various stages including collection, development, storage, and distribution.
YTD Price Performance: 60.68%
Average Trading Volume: 377,325
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.21B
See more data about BLFS stock on TipRanks’ Stock Analysis page.
